Viewing Study NCT04432857

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:55 PM
Ignite Modification Date: 2026-01-21 @ 3:00 PM
Study NCT ID: NCT04432857
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-27
First Post: 2020-06-11
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: AN0025 and Pembrolizumab Combination in Advanced Solid Tumors
Sponsor: Adlai Nortye Biopharma Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Triple-negative Breast Cancer View
None NSCLC, Squamous or Non-Squamous View
None Urothelial Carcinoma of the Bladder View
None Microsatellite Stable (MSS) Colorectal Cancer (CRC) View
None Cervical Cancer View
Keywords: